The discovery of MCC950, a selective inhibitor of the NLRP3 inflammasome, has been shown to remarkably reduce IL-1β production and infiltration of immunosuppressive cells, such as MDSCs, TAMs, and Tregs in the TME of HNSCC mouse model [169]. The gene discussed is NLRP3; the disease is head and neck squamous cell carcinoma.